5,915 reports of this reaction
7.2% of all LATANOPROST reports
#1 most reported adverse reaction
TREATMENT FAILURE is the #1 most commonly reported adverse reaction for LATANOPROST, manufactured by Viatris Specialty LLC. There are 5,915 FDA adverse event reports linking LATANOPROST to TREATMENT FAILURE. This represents approximately 7.2% of all 81,937 adverse event reports for this drug.
Patients taking LATANOPROST who experience treatment failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TREATMENT FAILURE is moderately reported among LATANOPROST users, representing a notable but not dominant share of adverse events.
In addition to treatment failure, the following adverse reactions have been reported for LATANOPROST:
The following drugs have also been linked to treatment failure in FDA adverse event reports:
TREATMENT FAILURE has been reported as an adverse event in 5,915 FDA reports for LATANOPROST. This does not prove causation, but indicates an association observed in post-market surveillance data.
TREATMENT FAILURE accounts for approximately 7.2% of all adverse event reports for LATANOPROST, making it one of the most commonly reported side effect.
If you experience treatment failure while taking LATANOPROST, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.